BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 34504503)

  • 1. The Cancer Epitope Database and Analysis Resource: A Blueprint for the Establishment of a New Bioinformatics Resource for Use by the Cancer Immunology Community.
    Koşaloğlu-Yalçın Z; Blazeska N; Carter H; Nielsen M; Cohen E; Kufe D; Conejo-Garcia J; Robbins P; Schoenberger SP; Peters B; Sette A
    Front Immunol; 2021; 12():735609. PubMed ID: 34504503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T Cell Epitope Prediction and Its Application to Immunotherapy.
    Schaap-Johansen AL; Vujović M; Borch A; Hadrup SR; Marcatili P
    Front Immunol; 2021; 12():712488. PubMed ID: 34603286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cancer Epitope Database and Analysis Resource (CEDAR).
    Koşaloğlu-Yalçın Z; Blazeska N; Vita R; Carter H; Nielsen M; Schoenberger S; Sette A; Peters B
    Nucleic Acids Res; 2023 Jan; 51(D1):D845-D852. PubMed ID: 36250634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery.
    de Sousa E; Lérias JR; Beltran A; Paraschoudi G; Condeço C; Kamiki J; António PA; Figueiredo N; Carvalho C; Castillo-Martin M; Wang Z; Ligeiro D; Rao M; Maeurer M
    Front Immunol; 2021; 12():592031. PubMed ID: 34335558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TANTIGEN 2.0: a knowledge base of tumor T cell antigens and epitopes.
    Zhang G; Chitkushev L; Olsen LR; Keskin DB; Brusic V
    BMC Bioinformatics; 2021 Apr; 22(Suppl 8):40. PubMed ID: 33849445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Recurrent Mutation in Anaplastic Lymphoma Kinase with Distinct Neoepitope Conformations.
    Toor JS; Rao AA; McShan AC; Yarmarkovich M; Nerli S; Yamaguchi K; Madejska AA; Nguyen S; Tripathi S; Maris JM; Salama SR; Haussler D; Sgourakis NG
    Front Immunol; 2018; 9():99. PubMed ID: 29441070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of Antigen-Specific T-Cell Receptor Clusters in Human Cancers.
    Zhang H; Liu L; Zhang J; Chen J; Ye J; Shukla S; Qiao J; Zhan X; Chen H; Wu CJ; Fu YX; Li B
    Clin Cancer Res; 2020 Mar; 26(6):1359-1371. PubMed ID: 31831563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput discovery of cancer-targeting TCRs.
    Bunse L; Green EW; Platten M
    Methods Enzymol; 2019; 629():401-417. PubMed ID: 31727251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ProTECT-Prediction of T-Cell Epitopes for Cancer Therapy.
    Rao AA; Madejska AA; Pfeil J; Paten B; Salama SR; Haussler D
    Front Immunol; 2020; 11():483296. PubMed ID: 33244314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational prediction of vaccine potential epitopes and 3-dimensional structure of XAGE-1b for non-small cell lung cancer immunotherapy.
    Tarek MM; Shafei AE; Ali MA; Mansour MM
    Biomed J; 2018 Apr; 41(2):118-128. PubMed ID: 29866600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New epitopes in ovalbumin provide insights for cancer neoepitopes.
    Karandikar SH; Sidney J; Sette A; Selby MJ; Korman AJ; Srivastava PK
    JCI Insight; 2019 Mar; 5(8):. PubMed ID: 30869653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TANTIGEN: a comprehensive database of tumor T cell antigens.
    Olsen LR; Tongchusak S; Lin H; Reinherz EL; Brusic V; Zhang GL
    Cancer Immunol Immunother; 2017 Jun; 66(6):731-735. PubMed ID: 28280852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico design of discontinuous peptides representative of B and T-cell epitopes from HER2-ECD as potential novel cancer peptide vaccines.
    Manijeh M; Mehrnaz K; Violaine M; Hassan M; Abbas J; Mohammad R
    Asian Pac J Cancer Prev; 2013; 14(10):5973-81. PubMed ID: 24289611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting cancer-specific mutations by T cell receptor gene therapy.
    Blankenstein T; Leisegang M; Uckert W; Schreiber H
    Curr Opin Immunol; 2015 Apr; 33():112-9. PubMed ID: 25728991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neoepitope landscape of breast cancer: implications for immunotherapy.
    Narang P; Chen M; Sharma AA; Anderson KS; Wilson MA
    BMC Cancer; 2019 Mar; 19(1):200. PubMed ID: 30832597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NEPdb: A Database of T-Cell Experimentally-Validated Neoantigens and Pan-Cancer Predicted Neoepitopes for Cancer Immunotherapy.
    Xia J; Bai P; Fan W; Li Q; Li Y; Wang D; Yin L; Zhou Y
    Front Immunol; 2021; 12():644637. PubMed ID: 33927717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Silico-Guided Sequence Modification of Epitopes in Cancer Vaccine Development.
    Hoo WPY; Siak PY; In LLA
    Methods Mol Biol; 2020; 2131():213-228. PubMed ID: 32162256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics for cancer immunology and immunotherapy.
    Charoentong P; Angelova M; Efremova M; Gallasch R; Hackl H; Galon J; Trajanoski Z
    Cancer Immunol Immunother; 2012 Nov; 61(11):1885-903. PubMed ID: 22986455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoinformatics and Epitope Prediction.
    Ramana J; Mehla K
    Methods Mol Biol; 2020; 2131():155-171. PubMed ID: 32162252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Landscape of Tumor Antigens in T Cell Immunotherapy.
    Ilyas S; Yang JC
    J Immunol; 2015 Dec; 195(11):5117-22. PubMed ID: 26589749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.